Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CONSULTATIVE GENOMICS, PLLC

NPI: 1417391533 · BELLAIRE, TX 77401 · Anatomic Pathology Physician · NPI assigned 04/19/2013

$184K
Total Medicaid Paid
8,399
Total Claims
4,671
Beneficiaries
46
Codes Billed
2018-09
First Month
2024-04
Last Month

Provider Details

Authorized OfficialROSENBLATT, KEVIN (OWNER)
NPI Enumeration Date04/19/2013

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 226 $66K
2019 1,873 $72K
2020 332 $10K
2021 587 $757.50
2022 4,833 $31K
2024 548 $4K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
81479 Unlisted molecular pathology procedure 500 80 $66K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 122 110 $43K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,499 575 $18K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 595 392 $11K
87486 484 363 $7K
87640 501 379 $7K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,688 705 $6K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 477 261 $6K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 286 221 $5K
81292 12 12 $2K
81298 12 12 $2K
G0452 Molecular pathology procedure; physician interpretation and report 207 170 $2K
80505 149 102 $2K
81295 12 12 $1K
81404 21 12 $1K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 43 42 $757.50
80506 149 102 $733.17
99451 120 90 $700.68
81226 30 30 $360.73
87150 48 46 $350.88
81225 31 31 $233.09
81350 30 30 $187.20
81328 30 30 $139.85
81335 30 30 $139.85
81247 17 17 $139.85
81232 31 31 $139.85
81230 31 31 $139.85
81227 30 30 $139.85
81231 31 31 $139.85
81401 19 19 $109.60
87581 220 100 $87.73
87541 233 114 $87.73
81355 30 30 $70.56
81241 30 30 $58.70
81240 30 30 $52.55
81291 30 30 $52.27
87481 19 18 $0.00
87653 19 18 $0.00
87631 234 116 $0.00
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 201 74 $0.00
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 21 20 $0.00
85025 Blood count; complete (CBC), automated, and automated differential WBC count 24 24 $0.00
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 14 14 $0.00
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 21 20 $0.00
80048 Basic metabolic panel (calcium, ionized) 17 17 $0.00
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 21 20 $0.00